Literature DB >> 17434661

Cavitational mechanisms in ultrasound-accelerated fibrinolysis.

Adrian F Prokop1, Azita Soltani, Ronald A Roy.   

Abstract

The role of both inertial and stable cavitation was investigated during in vitro ultrasound-accelerated fibrinolysis by recombinant tissue plasminogen activator (rt-PA) in the presence and absence of Optison. A unique treatment configuration applied ultrasound, rt-PA and Optison to the interior of a plasma clot. Lysis efficacy was measured as clot weight reduction. Cavitational mechanisms were investigated by monitoring subharmonic and broadband noise. In the absence of Optison, 1.7 MHz pulsed ultrasound with 1.5 MPa peak-negative pressure applied for 30 min resulted in 45 +/- 19% lysis enhancement relative to rt-PA alone. Cavitation was not detected, indicating a role of noncavitational effects of ultrasound. The addition of Optison increased lysis enhancement to 88 +/- 25%. Inertial cavitation was present only at the start of the exposure, while low-amplitude subharmonic emissions persisted throughout. Additional protocols suggested a possible correlation between the increased lysis in the presence of Optison and the subharmonic emission, indicating a potentially important role of stable rather than inertial cavitation in microbubble-enhanced ultrasound-accelerated rt-PA-mediated thrombolysis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17434661     DOI: 10.1016/j.ultrasmedbio.2006.11.022

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  49 in total

1.  Passive imaging with pulsed ultrasound insonations.

Authors:  Kevin J Haworth; T Douglas Mast; Kirthi Radhakrishnan; Mark T Burgess; Jonathan A Kopechek; Shao-Ling Huang; David D McPherson; Christy K Holland
Journal:  J Acoust Soc Am       Date:  2012-07       Impact factor: 1.840

Review 2.  Ultrasound-assisted thrombolysis for stroke therapy: better thrombus break-up with bubbles.

Authors:  Kathryn E Hitchcock; Christy K Holland
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

3.  Potentiating intra-arterial sonothrombolysis for acute ischemic stroke by the addition of the ultrasound contrast agents (Optison™ & SonoVue(®)).

Authors:  Azita Soltani; Ruchi Singhal; Melissa Obtera; Ronald A Roy; Wayne M Clark; Douglas R Hansmann
Journal:  J Thromb Thrombolysis       Date:  2011-01       Impact factor: 2.300

4.  Experimental demonstration of passive acoustic imaging in the human skull cavity using CT-based aberration corrections.

Authors:  Ryan M Jones; Meaghan A O'Reilly; Kullervo Hynynen
Journal:  Med Phys       Date:  2015-07       Impact factor: 4.071

5.  Sonothrombolysis: an emerging modality for the treatment of acute ischemic and hemorrhagic stroke.

Authors:  Azita Soltani; Wayne M Clark; Douglas R Hansmann
Journal:  Transl Stroke Res       Date:  2011-04-15       Impact factor: 6.829

6.  Spatial specificity and sensitivity of passive cavitation imaging for monitoring high-intensity focused ultrasound thermal ablation in ex vivo bovine liver.

Authors:  Kevin Haworth; Vasant A Salgaonkar; Nicholas M Corregan; Christy K Holland; T D Mast
Journal:  Proc Meet Acoust       Date:  2013-06-02

7.  Gauging the likelihood of stable cavitation from ultrasound contrast agents.

Authors:  Kenneth B Bader; Christy K Holland
Journal:  Phys Med Biol       Date:  2012-12-07       Impact factor: 3.609

8.  Clot retraction affects the extent of ultrasound-enhanced thrombolysis in an ex vivo porcine thrombosis model.

Authors:  Jonathan T Sutton; Nikolas M Ivancevich; Stephen R Perrin; Deborah C Vela; Christy K Holland
Journal:  Ultrasound Med Biol       Date:  2013-03-01       Impact factor: 2.998

9.  Ultrasound-enhanced thrombolysis with tPA-loaded echogenic liposomes.

Authors:  George J Shaw; Jason M Meunier; Shao-Ling Huang; Christopher J Lindsell; David D McPherson; Christy K Holland
Journal:  Thromb Res       Date:  2009-02-13       Impact factor: 3.944

Review 10.  Ultrasound-mediated drug delivery for cardiovascular disease.

Authors:  Jonathan T Sutton; Kevin J Haworth; Gail Pyne-Geithman; Christy K Holland
Journal:  Expert Opin Drug Deliv       Date:  2013-03-01       Impact factor: 6.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.